New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
- Cambridge Epigenetix
- Citibase Cambridge, Sheraton House
- Castle Park
- Cambridge , CB3 0AX
- UNITED KINGDOM
Cambridge Epigenetix is a biosciences company developing epigenetics research tools. It aims to develop technologies that have a significant impact on next-generation sequencing systems, methylation arrays, and targeted assays resulting in new avenues for research, pharmaceutical discovery, and diagnostics.